Delivery Order SPE2DB25D7056-SPE2DB25FTMAV

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,104.30 firm fixed price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.20 firm fixed-price delivery order covers the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.55 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.10 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, with a completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is the prime contractor and holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.00 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product. The award has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price of $1,088.50 and an ultimate completion date of November 27, 2024. This award is a delivery order under a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,052.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tubersol 5T unit/0.1 mL vial 5 mL, a medical product used for tuberculosis testing. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML medical supplies, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $4,190.60 firm fixed-price contract, awarded on December 11, 2024, has a completion date of December 12, 2024. The contract is structured as a delivery order, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is associated with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,847.40 firm-fixed-price delivery order is for 4,557,533,935 units of Tubersol 5T (0.1 ML vial, 5 ML), a tuberculin purified protein derivative used for tuberculosis testing. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,200.00, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 14, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTMAV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.35 firm fixed-price delivery order is for the provision of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical commodity.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:54 AM